How to Detect Atrial Fibrillation (Afib) at Home

Detecting atrial fibrillation at home is now possible through several methods, from checking your own pulse to using a smartwatch or a dedicated handheld ECG device. None of these replace a clinical diagnosis, but the technology has reached a point where consumer devices can flag irregular heart rhythms with surprisingly high accuracy. The challenge is knowing which tools work best, what their blind spots are, and what to actually do when one of them alerts you.

Why Home Detection Matters

Atrial fibrillation often flies under the radar. A recent systematic review and meta-analysis estimated that roughly 27% of people with AF have no symptoms at all, making it genuinely silent in more than a quarter of cases.¹ That same analysis found that men, people with diabetes, those with chronic kidney disease, and people who had already experienced a stroke or mini-stroke were more likely to have silent AF. An earlier study of patients with a history of arrhythmias found that 17% developed asymptomatic AF within six months, detected only because they were being continuously monitored.²

Silent AF carries real consequences. The stroke risk associated with undetected AF is well established, and research on patients with implanted cardiac devices confirms that even episodes a person never feels still increase the risk of blood clots traveling to the brain.³ This is the core reason home detection tools exist: if you cannot feel it, you need something else to catch it.

The Simplest Method You Already Have

Before any device enters the picture, you can check your own pulse. Place two fingers on the inside of your wrist, just below the thumb, and count beats for 30 seconds. In normal rhythm, the beats arrive at roughly even intervals, like a metronome. In AF, the spacing between beats is chaotic and unpredictable. Some beats come quickly, some slowly, with no pattern at all. Doctors call this an “irregularly irregular” pulse, and it is the hallmark you are feeling for.

Pulse checking is free, requires no technology, and can be done anywhere. Its limitation is that it depends on your ability to notice subtle irregularities, and it misses AF episodes that happen while you are not actively checking. Still, it is the oldest screening method and remains a standard first step in clinical guidelines. A cost-effectiveness analysis found that pulse palpation followed by a confirmatory ECG was actually cost-saving compared to no screening at all, coming in at about $43 saved per person while still catching additional cases.⁴

Smartwatches and Fitness Trackers

The most accessible high-tech option for most people is a smartwatch. Devices from Apple, Samsung, Fitbit, and Withings all include algorithms that analyze your heart rhythm using a green light sensor on the back of the watch. This sensor measures tiny changes in blood volume in your wrist’s blood vessels with every heartbeat. When the spacing between those pulses becomes irregular in a way consistent with AF, the watch sends you a notification.

A large meta-analysis covering 26 studies and over 17,000 patients found that smartwatches achieved an overall sensitivity of 95% and specificity of 97% for detecting AF. The Apple Watch hit 94% sensitivity and 97% specificity, Samsung devices reached 97% and 96%, and the Withings ScanWatch came in at 89% and 95%.⁵ Those are strong numbers for a screening tool. But they come with context that matters.

The Fitbit Heart Study, which enrolled over 455,000 participants, gave a more real-world picture. Among participants who received an irregular rhythm notification and then wore an ECG patch for confirmation, about 32% actually had AF.⁶ That may sound low, but when the same Fitbit flagged an irregular rhythm at the exact same moment the ECG patch was recording, the positive predictive value jumped to 98%. The gap between those two numbers reflects a key challenge: AF comes and goes. A watch might correctly detect an episode during a brief window, but by the time you strap on a confirmation monitor days later, the episode may have passed.

A head-to-head clinical validation study of five consumer wearables painted a more conservative picture than the meta-analysis, finding sensitivities ranging from 58% to 85% and specificities from 69% to 79% across the Apple Watch, Samsung Galaxy Watch, Withings ScanWatch, Fitbit Sense, and AliveCor KardiaMobile. That same study noted that between 17% and 26% of tracings were inconclusive, meaning the algorithm could not determine the rhythm at all.⁷ The gap between meta-analytic pooled data and a single prospective study is worth keeping in mind: real-world performance depends on factors like how tightly the watch fits, how much you move your wrist, and individual variations in skin and circulation.

Handheld Single-Lead ECG Devices

If you want something closer to an actual electrocardiogram without visiting a clinic, handheld single-lead ECG devices are the next step up. The most widely studied is the AliveCor KardiaMobile, a small sensor pad you press your fingers against for 30 seconds. Some smartwatches, including the Apple Watch and Samsung Galaxy Watch, also have built-in single-lead ECG capabilities activated by touching the watch’s crown or bezel.

A review by the UK’s National Institute for Health and Care Excellence, summarized across nine studies of four single-lead ECG devices, found a pooled sensitivity of about 91% and specificity of 96% for AF detection. The KardiaMobile specifically achieved a pooled sensitivity of 94% and specificity of 97%.⁸ A separate study comparing KardiaMobile recordings to standard 12-lead ECGs in 100 consecutive patients at a cardiovascular center found a sensitivity of about 93% and perfect specificity for AF.⁹

A meta-analysis comparing the two main categories of home devices found that pulse-based (PPG) tools had pooled sensitivity of 93% but specificity of 91%, while handheld ECG devices had lower sensitivity at 87% but higher specificity at 96%.¹⁰ In practical terms, pulse-based watches are better at catching AF when it is there, while handheld ECGs are better at correctly ruling it out when it is not. The tradeoff depends on your situation: if you are at high risk and want to cast a wide net, a continuously monitoring smartwatch has appeal. If you feel palpitations and want a quick, reliable recording to show your doctor, a handheld ECG may be more useful.

Blood Pressure Monitors With AF Detection

A less obvious but increasingly available option is an automatic blood pressure cuff with a built-in AF screening feature. Several models from Microlife, Omron, and others analyze the rhythm of your heartbeat while inflating and deflating the cuff. If the beat-to-beat intervals look irregular in a pattern consistent with AF, the monitor displays an AF alert alongside your blood pressure reading.

A meta-analysis of blood pressure monitors used for AF screening, covering over 11,000 people, found pooled sensitivity of 97% and specificity of 93%.¹¹ The negative predictive value was 99%, meaning that if the monitor says you do not have AF, it is almost certainly right. A validation study of the Microlife BP B3 AFIB Advanced, which checks rhythm three times during each blood pressure measurement, found 87% sensitivity and 100% specificity.¹²

This approach is particularly well suited for people who already check their blood pressure at home, especially older adults managing hypertension. You get AF screening as a free bonus with something you are doing anyway. One caveat: arm movement during measurement can trigger false positives. A study that included 99 patients found diagnostic accuracy climbed from about 88% to 91% when measurements affected by body movement were excluded.¹³ Sit still and keep your arm relaxed on a table.

What Triggers False Alarms

The biggest practical nuisance with home AF detection is false positives. The most common culprit is premature beats: premature atrial contractions (PACs) and premature ventricular contractions (PVCs). These are extra heartbeats that nearly everyone experiences occasionally. They create irregular pulse intervals that can look a lot like AF to a watch’s algorithm. One ambulatory study found that 9 out of 10 false-positive AF alerts from a smartwatch were caused by premature beats.¹⁴ PACs and PVCs are usually harmless, but they can generate repeated alerts that feel alarming if you do not know what is happening.

Motion artifacts are another common cause. Wrist-based sensors struggle during exercise, hand gestures, or any activity that shifts the watch on your skin. Cold temperatures and poor blood flow can also weaken the signal. For people with darker skin tones, there has been concern that optical sensors might perform differently, though the evidence is mixed. A large-scale trial found that the diagnostic yield of confirmed AF after an irregular rhythm notification was lower among Black non-Hispanic participants compared to White non-Hispanic participants, and a smaller validation study found lower sensitivity in the Black/African American subgroup.¹⁵ Some researchers have argued the arrhythmia-detection algorithms themselves remain robust across skin tones, pointing to the Apple Heart Study’s large-scale data.¹⁶ The honest picture is that more data is needed, and the discrepancy may involve differences in healthcare access and follow-up rather than sensor physics alone.

AF Comes and Goes, and That Changes Everything

One of the trickiest aspects of detecting AF at home is that the arrhythmia is often intermittent. In a randomized trial that used continuous ECG patches worn for about two weeks, among people diagnosed with new AF, the median duration of the longest individual AF episode was about three hours. Over half had their longest episode lasting between five minutes and six hours, while about 7% had episodes shorter than five minutes.¹⁷ The median AF burden, meaning the percentage of monitored time actually spent in AF, was under 1%.

This has huge implications for home detection. If AF is present less than 1% of the time, a single spot-check with a handheld ECG or a blood pressure cuff might easily miss it. A study comparing a wrist-worn AI device to standard 24-hour Holter monitoring found that extending the monitoring window from one day to 28 days increased the detected AF prevalence from what the Holter alone picked up to nearly 27%, because the longer monitoring period captured paroxysmal episodes that the short Holter window missed.¹⁸ Continuous monitoring, like a smartwatch worn daily, has a structural advantage over intermittent spot-checks for exactly this reason.

What to Do When Your Device Flags Something

Getting an irregular rhythm notification from a watch or blood pressure monitor is not, by itself, a diagnosis. You need clinical confirmation. In practice, a survey of physicians presented with an asymptomatic Apple Watch irregular rhythm notification found that nearly all ordered at least one diagnostic test. The most common was a standard 12-lead ECG, ordered in 96% of cases, followed by ambulatory rhythm monitoring in 77%, and echocardiography in about a third of cases. On average, physicians ordered 2.3 tests per notification. About a quarter also started new medication, and roughly 19% initiated a referral to another specialist.¹⁹

That clinical pathway sounds reassuring, but the evidence becomes thinner the further down the chain you go. Detection technology has been studied extensively. What happens after detection, including whether wearable-initiated diagnoses lead to better outcomes like fewer strokes or lower mortality, is much less settled. A recent review noted that the strength of evidence “diminishes at each link” from detection through notification, confirmation, treatment, and ultimately outcomes, and that unresolved problems remain around pathway heterogeneity, workflow burden, and overdiagnosis.²⁰ In other words, these devices are very good at finding AF, but the medical system has not fully figured out the best way to handle what they find.

AI Is Improving What Devices Can Do

Artificial intelligence is reshaping the accuracy of home ECG readings. Traditional built-in device algorithms use fixed rules to classify rhythms, and they produce a high rate of “unreadable” or “inconclusive” results. A deep learning AI platform tested on single-lead ECG recordings achieved overall accuracy above 96% and a negative predictive value of about 98%, outperforming the rules-based algorithm on every metric.²¹

Another clinical validation used a deep neural network algorithm across recordings from five different smart devices. The AI-based system produced conclusive readings in 96% to 99% of tracings, compared to just 74% to 85% for the manufacturer algorithms. The improvement was consistent across all five device brands, and sensitivity and specificity for AF detection were statistically equivalent regardless of which device recorded the signal.²² The practical upside here is fewer frustrating “inconclusive” results and more useful data from the same hardware you already own.

Camera-Based Detection Without Touching Anything

One of the more unexpected approaches to home AF detection uses nothing more than a smartphone camera pointed at your face. The technology, called remote photoplethysmography (rPPG) or videoplethysmography (VPG), captures subtle color changes in facial skin caused by blood flowing through capillaries with each heartbeat. Software analyzes the timing of these micro-fluctuations to estimate pulse intervals and flag irregular rhythms.

In one study, a deep learning model analyzing facial video recordings achieved 90% accuracy at discriminating AF from normal rhythm in 30-second clips, and that accuracy rose to 97% with 10-minute recordings.²³ A clinical experiment measuring pulse rate via front-facing cameras on a Samsung smartphone and tablet found that the mean difference between video-based and ECG-based heart rate measurements was less than 1 beat per minute.²⁴ A separate assessment tested the method across different skin tones and found sensitivity of about 96% and specificity of 92% for AF detection, provided the ambient light was at least 100 lux, roughly the level of a normally lit room.²⁵

This technology is not yet built into consumer apps in a regulated way, but it represents a genuinely contactless option that could eventually make screening as easy as a brief video call.

The Psychological Side of Constant Monitoring

Wearing a device that watches your heart rhythm around the clock sounds like pure upside, but it can come with emotional costs. A study comparing AF patients who used wearables to those who did not found that wearable users reported higher rates of symptom preoccupation and more worry about their treatment. About 20% of wearable users experienced anxiety and said they always contacted their doctors in response to irregular rhythm notifications. The wearable group also used more AF-related healthcare, including significantly higher rates of ECGs, echocardiograms, and ablation procedures.²⁶

Whether that extra healthcare use represents appropriate vigilance or anxious overconsumption is an open question. For people already diagnosed with AF, constant alerts may reinforce a cycle of checking, worrying, and seeking reassurance. A usability study of smartwatch-based AF monitoring in older stroke survivors found that each additional year of age was associated with about 6% higher odds of reporting anxiety or worry related to the device, and people with baseline anxiety or depression were more likely to be distressed by it.²⁷ If you tend toward health anxiety, having a frank conversation with your doctor about how to interpret notifications before strapping on a monitoring device is worth the time.

Choosing the Right Tool for Your Situation

No single device is ideal for every person, and thinking about what you actually need narrows the field quickly. If you are at low risk and just want a general early warning system, a smartwatch you already own and wear daily is probably enough. The passive monitoring catches episodes you would never feel, and the accuracy for AF is high. If you get occasional palpitations and want a recording you can email to your cardiologist, a handheld single-lead ECG device like the KardiaMobile is harder to beat: it produces a tracing a doctor can interpret directly, and its specificity for AF is excellent. If you are an older adult already monitoring blood pressure at home, switching to a cuff with AF detection built in adds screening with zero extra effort.

Cost is a real factor. The same cost-effectiveness analysis that found pulse palpation cheapest also found that a wrist-worn PPG device followed by a wrist-worn single-lead ECG and confirmatory patch monitoring was cost-effective at roughly $58,000 per quality-adjusted life year gained, well within the range health systems typically consider worthwhile.⁴ But that analysis assumes structured follow-up. If you get an alert and ignore it, or if the healthcare system does not have a clear pathway to respond, the screening loses its value entirely. The technology is only as good as what you do with the result.